ADAM17 and inflammation: Activated lung macrophages have also been shown to enhance IL6 trans-signaling via ADAM-17 leading to fibroblast proliferation and ECM deposition, and inhibition of sIL6Rα can attenuate pulmonary inflammation and fibrosis (52).